Evolution and Comparative Analysis of Hospitalizations in Spain Due to COPD and Bronchiectasis between 2004 and 2015

References

• Barker AF. Bronchiectasis. N Engl J Med. 2002;346(18):1383–1393. DOI:https://doi.org/10.1056/NEJMra012519
   PubMed Web of Science ®Google Scholar
• King PT, Holdsworth SR, Freezer NJ, et al. Outcome in adult bronchiectasis. COPD. 2005;2(1):27–34. DOI:https://doi.org/10.1081/copd-200050685
   PubMedGoogle Scholar
• Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138(4):944–949. DOI:https://doi.org/10.1378/chest.10-0099
   PubMed Web of Science ®Google Scholar
• Ringshausen FC, de Roux A, Pletz MW, et al. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One. 2013;8(8):e71109. DOI:https://doi.org/10.1371/journal.pone.0071109
   PubMed Web of Science ®Google Scholar
• Sánchez-Muñoz G, López de Andrés A, Jiménez-García R, et al. Time trends in hospital admissions for bronchiectasis: analysis of the Spanish national hospital discharge data (2004 to 2013). PLoS One. 2016;11(9):e0162282. DOI:https://doi.org/10.1371/journal.pone.0162282
   PubMed Web of Science ®Google Scholar
• Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, et al. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016;20(1):11–23. DOI:https://doi.org/10.5588/ijtld.15.0472
   PubMed Web of Science ®Google Scholar
• Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):7–16. DOI:https://doi.org/10.1016/j.ccm.2013.10.002
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. DOI:https://doi.org/10.1183/09031936.06.00124605
   PubMed Web of Science ®Google Scholar
• Soriano JB, Alfageme I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021;57(1):61–69. DOI:https://doi.org/10.1016/j.arbr.2020.07.017
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI:https://doi.org/10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Dang-Tan T, Ismaila A, Zhang S, et al. Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review. BMC Res Notes. 2015;8:464. DOI:https://doi.org/10.1186/s13104-015-1427-y
   PubMedGoogle Scholar
• Ni Y, Shi G, Yu Y, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1465–1475. DOI:https://doi.org/10.2147/COPD.S83910
   PubMed Web of Science ®Google Scholar
• Du Q, Jin J, Liu X, et al. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150532. DOI:https://doi.org/10.1371/journal.pone.0150532
   PubMed Web of Science ®Google Scholar
• O’Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000; 55(8):635–642.
   PubMed Web of Science ®Google Scholar
• Goeminne PC, Hernandez F, Diel R, et al. The economic burden of bronchiectasis - known and unknown: a systematic review. BMC Pulm Med. 2019;19(1):54. DOI:https://doi.org/10.1186/s12890-019-0818-6
   PubMed Web of Science ®Google Scholar
• Explotación estadística del Conjunto Mínimo Básico de Datos Hospitalarios Nota Metodológica - NORMA ESTATAL [Internet]. [cited 2019 apr 14]. available at http://www.mscbs.gob.es/estadEstudios/estadisticas/docs/NORMAGRD2011/norma_estatal_2011_notas_metod.pdf.
   Google Scholar
• Instituto Nacional de Estadística (INE). [Internet]. [cited 2019 April 14]. available at http://www.ine.es.
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619. DOI:https://doi.org/10.1016/0895-4356(92)90133-8
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. DOI:https://doi.org/10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Sánchez-Muñoz G, Lopez-de-Andrés A, Hernández-Barrera V, et al. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender. PLoS One. 2019;14(1):e0211222. DOI:https://doi.org/10.1371/journal.pone.0211222
   PubMed Web of Science ®Google Scholar
• Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47(1):186–193. DOI:https://doi.org/10.1183/13993003.01033-2015
   PubMed Web of Science ®Google Scholar
• De la Rosa D, Martínez-Garcia MA, Olveira C, et al. Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence. Chron Respir Dis. 2016;13(4):361–371. DOI:https://doi.org/10.1177/1479972316643698
   PubMed Web of Science ®Google Scholar
• Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831. DOI:https://doi.org/10.1164/rccm.201208-1518OC
   PubMed Web of Science ®Google Scholar
• Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014;11(6):605–614. DOI:https://doi.org/10.3109/15412555.2014.922174
   PubMedGoogle Scholar
• Garcia Vidal C, Almagro P, Romani V, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbations: a prospective study. Eur Respir J. 2009;34(5):1072–1078. DOI:https://doi.org/10.1183/09031936.00003309
   PubMed Web of Science ®Google Scholar
• Chung WS, Lin CL. Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study. Respir Med. 2018;140:6–10. DOI:https://doi.org/10.1016/j.rmed.2018.05.008
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Miravitlles M. Bronchiectasis in COPD patients: more than a comorbidity? Int J Chron Obstruct Pulmon Dis. 2017;12:1401–1411. DOI:https://doi.org/10.2147/COPD.S132961
   PubMed Web of Science ®Google Scholar
• Ford ES. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. Chest. 2015;147(4):989–998. DOI:https://doi.org/10.1378/chest.14-2146
   PubMed Web of Science ®Google Scholar
• Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD. 2017;14(1):72–79. DOI:https://doi.org/10.1080/15412555.2016.1199669
   PubMedGoogle Scholar
• De Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–723. DOI:https://doi.org/10.1016/j.rmed.2013.01.007
   PubMed Web of Science ®Google Scholar
• Seifer FD, Hansen G, Weycker D. Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice. Chron Respir Dis. 2019;16:1479973119839961. DOI:https://doi.org/10.1177/1479973119839961
   Web of Science ®Google Scholar
• Portal Estadístico. Área de inteligencia de gestión [internet]. [cited 2019. April 14]. available at https://pestadistico.inteligenciadegestion.mscbs.es/publicoSNS/S.
   Google Scholar
• De la Rosa Carrillo D, Navarro Rolon A, Girón Moreno RM, et al. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis. Respiration. 2018;96(5):406–416. DOI:https://doi.org/10.1159/000489935
   PubMed Web of Science ®Google Scholar
• Seitz AE, Olivier KN, Adjemian J, et al. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142(2):432–439. DOI:https://doi.org/10.1378/chest.11-2209
   PubMed Web of Science ®Google Scholar
• Ringshausen FC, de Roux A, Diel R, et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46(6):1805–1807. DOI:https://doi.org/10.1183/13993003.00954-2015
   PubMed Web of Science ®Google Scholar
• Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4):205–209. DOI:https://doi.org/10.1097/01.cpm.0000171422.98696.ed
   Google Scholar